title: The epidemiology of hepatitis A infection in Palestine: a universal vaccination programme is not yet needed.
abstract: In Palestine, there has been an increase in the reported incidence of acute hepatitis A virus (HAV) infection since 1995. Since overt clinical disease occurs only among adults, questions were raised whether or not a shift in the epidemiology of HAV has occurred. This is generally characterized by a decrease in the overall incidence rate and a shifting in the mean age of infection towards adolescence and early adulthood. The need for a vaccination programme is being discussed. To resolve this issue, we examined the prevalence of anti-HAV in a representative sample of 396 school children in the Gaza Strip. The prevalence of anti-HAV was 93.7% (95% CI: 91.3, 96.1%). Stratifying the prevalence by age showed that 87.8% (95% CI: 78.6, 97%) were HAV antibody positive by the age of 6. By the age of 14, almost 98% (95% CI: 92.7, 100%) were HAV antibody positive. This means that the majority of HAV infection is still taking place in early childhood, when it is usually asymptomatic and of little clinical significance. The results refuted the shifting epidemiology theory and we recommend that a vaccination programme against HAV infection is not yet needed. Alternative explanations for the increase in reported cases are discussed.
authors.affiliation: Section of International Public Health, School of Public Health, University of Bielefeld, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Yassin
authors.forename: R
authors.initials: R
authors.lastname: Awad
authors.forename: A
authors.initials: A
authors.lastname: Tebi
authors.forename: A
authors.initials: A
authors.lastname: Queder
authors.forename: U
authors.initials: U
authors.lastname: Laaser
mesh_terms: D000293:Adolescent; D000375:Aging / Q000276:immunology*; D002648:Child; D005260:Female; D006506:Hepatitis A / Q000453:epidemiology* / Q000276:immunology; D035922:Hepatitis A Antibodies; D006508:Hepatitis Antibodies / Q000302:isolation & purification*; D006801:Humans; D015994:Incidence; D008297:Male; D008877:Middle East / Q000453:epidemiology; D015995:Prevalence; D016036:Seroepidemiologic Studies; D014611:Vaccination
chemical_list: D035922:Hepatitis A Antibodies; D006508:Hepatitis Antibodies